Phase 3 study of Elamipretide in patients with primary mitochondrial myopathies

Trial Profile

Phase 3 study of Elamipretide in patients with primary mitochondrial myopathies

Planning
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Mitochondrial myopathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2016 New trial record
    • 17 Jun 2016 Accoding to Stealth Biotherapeutics media release, the United Mitochondrial Disease Foundation (UMDF) symposium and the broader advocacy community look forward to fully supporting this upcoming Phase 3 trial.
    • 17 Jun 2016 Accoding to Stealth Biotherapeutics media release, company will initiate discussions with the FDA to develop this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top